---
figid: PMC6912706__cells-08-01336-g002
figlink: /pmc/articles/PMC6912706/figure/cells-08-01336-f002/
number: F2
caption: 'SGA-induced impairment in hepatic insulin signaling and glucose metabolism.
  SGAs impact the insulin signaling pathway at two levels: inhibition of IRS-1/2 phosphorylation
  and inhibition of AKT and GSK3 phosphorylation, with H1R antagonism being the proposed
  SGA target in insulin signaling impairment. Antagonism of 5-HT1 and 5-HT2A and inhibition
  of glycogen phosphorylase (GP) would decrease glycogen synthesis, an effect also
  enhanced by inhibition of glycogen synthase (GS). Both inhibition of glycogen synthesis
  and stimulation of gluconeogenesis by SGAs increase the hepatic glucose output (HGO),
  leading to an increase in blood glucose levels. SGAs have been also shown to activate
  both hepatic catabolic (AMPK) and anabolic (mTORC1) pathways and also induce ROS
  production and mitochondrial dysfunction.'
pmcid: PMC6912706
papertitle: 'Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism:
  Beyond Weight Gain.'
reftext: Diana Grajales, et al. Cells. 2019 Nov;8(11):1336.
pmc_ranked_result_index: '14915'
pathway_score: 0.969047
filename: cells-08-01336-g002.jpg
figtitle: SGA-induced impairment in hepatic insulin signaling and glucose metabolism
year: '2019'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6912706__cells-08-01336-g002.html
  '@type': Dataset
  description: 'SGA-induced impairment in hepatic insulin signaling and glucose metabolism.
    SGAs impact the insulin signaling pathway at two levels: inhibition of IRS-1/2
    phosphorylation and inhibition of AKT and GSK3 phosphorylation, with H1R antagonism
    being the proposed SGA target in insulin signaling impairment. Antagonism of 5-HT1
    and 5-HT2A and inhibition of glycogen phosphorylase (GP) would decrease glycogen
    synthesis, an effect also enhanced by inhibition of glycogen synthase (GS). Both
    inhibition of glycogen synthesis and stimulation of gluconeogenesis by SGAs increase
    the hepatic glucose output (HGO), leading to an increase in blood glucose levels.
    SGAs have been also shown to activate both hepatic catabolic (AMPK) and anabolic
    (mTORC1) pathways and also induce ROS production and mitochondrial dysfunction.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS2
  - IRS1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - AKT2
  - AKT3
  - AKT1
  - GSK3A
  - GSK3B
  - FOXO1
  - glucose
  - 5-HT
  - GS
genes:
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Foxo1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
- word: 5-HT
  source: MESH
  identifier: D012701
diseases:
- word: GS
  source: MESH
  identifier: D011125
figid_alias: PMC6912706__F2
redirect_from: /figures/PMC6912706__F2
figtype: Figure
---
